Background Some clinicians suspect that breast milk fortifier may increase risk of necrotising enterocolitis in preterm babies 1 although there is no evidence for this. 2 However there is risk of contamination of breastmilk during fortification, in addition vigorous shaking risks damage to delicate immunological components, and storage for longer than 12 hours leads to coalescing of milk fat globules 3 with reduced surface area for digestion. In 2012 a guideline using a novel method to prepare fortified breastmilk was written to address these concerns; it combed several practices to ensure milk safety. Fortifier is dissolved in 3 ml of breastmilk at the time of preparation to avoid the need for shaking. The concentrate is then used to accurately prepare low volume fortified milk precluding the need for storage over 12 hours. Each step is carried out using aseptic handling. Aims To audit compliance with this novel method of fortification within a tertiary neonatal unit. Methods Approval was granted by the local audit committee. The guideline was evaluated by observation of 40 separate preparations of fortified breastmilk during 2 weeks in 2016. All fortification was carried out in the nursery as the unit has no milk kitchen. Seventeen steps were identified and compliance noted for each. Four steps around labelling, 7 around aseptic technique, and 6 around handling. Results Compliance achieved,ffor labelling 84% of time, aseptic technique 60% and handling 83%.Non-compliance around handling was most common when fortifier was added to large volumes of breastmilk, leading to vigorous shaking of milk to dissolve powder. Conclusion Non-compliance with aseptic techniques when preparing fortified breast milk is high. This needs to be addressed with ongoing nurse education around the potential risks to milk quality. Aims Preterm infants requiring small bowel resection may receive a temporising enterostomy to divert the faecal stream and allow optimisation of their clinical condition and nutritional status prior to restoration of intestinal continuity. Facilitating growth in the presence of an enterostomy can be challenging, and may require adjuvant parenteral nutrition in addition to enteral feeds. There remains no consensus regarding the optimal timing of stoma closure. We aimed to determine the stoma-related complication rate in preterm neonates undergoing small bowel resection and enterostomy formation to help inform discussions about the timing of stoma closure. Methods We retrospectively identified all infants<32 weeks gestation who underwent small bowel resection and enterostomy formation between January 2012 and June 2017, from our surgical procedures database. Information including basic demographics, indication for enterostomy, timing of formation and closure and associated complications were extracted from case records. Local Caldicott Guardian approval was obtained.
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Results 34 neonates were identified with a median gestational age and birth weight of 27+3 weeks (range 23+2-31+6) and 933 grams (range 480-2050) respectively. Indications for enterostomy formation were necrotising enterocolitis (NEC) in 16 (47%) infants, spontaneous intestinal perforation in 9 (26%) and 'other' in 9 (26%). The overall median age at stoma formation was 26 days (range 3-97); with a median age of 44 days (range 6-71) in infants with NEC, compared to 15 days (range 3-97) for all other infants. Median age at stoma closure was 105 days (range 27-394). 27 neonates (79%) required adjuvant parenteral nutrition via central venous access and 14 (51%) of these developed a central line associated complication. There were 7 stoma-related complications comprising 3 stoma prolapse, 1 wound dehiscence and 3 superficial wound breakdown. Conclusions Complications directly related to an enterostomy, or due to a requirement for central venous access and parenteral nutrition are common in preterm infants. These data should inform multidisciplinary discussion regarding the risks and benefits of persevering with an enterostomy versus early closure. Aims Chronic lung disease affects up to a third of babies born prematurely in the UK. 1 For some, this necessitates discharge home on supplemental oxygen. Criteria for identifying these ex-preterms vary between units. Increasing use of formal saturation profiles using the newest saturation recording devices in apparently asymptomatic babies reveals previously unsuspected reduction in oxygen saturations. Significant dips to 74% occurred in 3 subjects, all coincident with handling, feeding and/or changing. Collecting data has been hampered by frequent movement artefact triggering alarms and resulting in removal of sensors. The study is ongoing, and a time-dependent reference range will be constructed using a hierarchical regression approach to summarising data, in order to deal with covariance and increase resolution of the final range. We anticipate that greater number of data points will result in widening of the reference range at the lower end. Conclusions Interim data using the next generation of monitors demonstrate oxygen saturations>93% for>95% of the time, in healthy newborns, suggesting that this should remain the target for ex-preterm babies when discharged home. Recording normative data may be improved with a two point sensor application to minimise movement artefact.
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Background Exposure to deficient or excess glucocorticoids is associated with increased morbidity in patients with adrenal insufficiency. An age-appropriate low dose hydrocortisone formulation is not available and manipulation of adult medication is required with potential for inaccurate dosing. Licensed pharmaceutical products must contain ±10% of labelled drug content.
Aims To assess the variability in manipulation procedures undertaken by parents/carers and to quantify the dose-variability in the manipulated product based on the method of preparation.
Methods Parents of children with adrenal insufficiency completed a survey assessing the methods used to manipulate hydrocortisone 10 mg tablets. A sub-group were asked to manipulate a scored 10 mg hydrocortisone tablet (Auden Mackenzie brand) to provide the prescribed dose for their child as they would at home. Hydrocortisone content was analysed according to the current European Pharmacopoeial method.
Results One hundred and twenty-nine parents completed the questionnaire. Overall 55% of parents break or cut the tablet and 43% suspend the tablet in water prior to administration. 34% are prescribed a dose indivisible by 2.5 mg of whom 33% break the tablet to acquire the dose. Twenty-seven parents/carers participated in the sub-study and the target doses they prepared ranged from 0.5-7.5 mg. Forty eight percent of the preparations were within 10% of the target dose; 74% were within 20% and 82% were within 30%. Based on this small sample size the most accurate method of tablet manipulation is to split the tablet along the score lines. However, this is only possible for doses divisible by 2.5 mg. Dispersion of the tablet in water and withdrawal of the relevant volume was associated with poor accuracy.
Conclusions Children are at risk of suboptimal dosing when parents/carers are required to manipulate adult products to provide the appropriate dose to children. This risk is greatest
